Risk factors and prevalence of hepatitis virus B and C serum markers among nurses at a tertiary-care hospital in Mexico City, Mexico: A descriptive study

Annals of Hepatology

Volumn 5, Issue 4, 2006, Pages 276-280

  Méndez Sánchez, Nahum ^a   Motola Kuba, Daniel ^a   Zamora Valdés, Daniel ^a   Sánchez Lara, Karla ^a   Ponciano Rodríguez, Guadalupe ^b   Uribe Ramos, Martha H ^a   Vásquez Fernández, Francisco ^a   Lezama Mora, Jezer ^a   Pérez Sosa, Julio A ^a   Baptista González, Héctor A ^a   Uribe, Misael ^a  

^a LIVER RESEARCH UNIT   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Hepatitis B virus; Hepatitis C virus; Mexico; Prevalence; Risk factors; Viral hepatitis

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEXICO; NURSING STAFF; PREVALENCE; QUESTIONNAIRE; SEROLOGY; SEXUAL BEHAVIOR; TATTOOING; TERTIARY HEALTH CARE; VIRUS LOAD;

EID: 33845389798     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31988-x     Document Type: Article

References (26)

1. Principales causas de mortalidad general 2003. http://sinais.salud.gob. mx/mortalidad/mortalidad.htm
2. Mendez-Sanchez N, Villa AR, Chavez-Tapia NC, Ponciano-Rodriguez G, Almeda-Valdes P, Gonzalez D, Uribe M. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005; 4: 52-5.
3. Mendez-Sanchez N, Aguilar-Ramirez JR, Reyes A, Dehesa M, Juarez A, Castañeda B, Sanchez-Avila F, Poo JL, Guevara Gonzalez L, Lizardi J, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004; 3: 30-3.
4. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962-73.
5. National Consensus of Hepatitis C. In: Ann Hepatol; 2002; Asociación Mexicana de Hepatología. 148-54.
6. Mendez-Sanchez N, Baptista-Gonzalez H, Sanchez-Gomez RH, Bordes-Aznar J, Uribe-Esquivel M. The prevalence of hepatitis B and C in blood donors in a 3rd-level hospital of Mexico City. Salud Publica Mex 1999; 41: 475-8.
7. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558-67.
8. Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzalez A, Hernandez JM, Roget M, Vargas V, Genesca J, Buti M, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294-7.
9. Mendez-Sanchez N, Motola-Kuba D, Chavez-Tapia NC, Bahena J, Correa-Rotter R, Uribe M: Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico. J Clin Microbiol 2004; 42: 4321-2.
10. Seeff LB: Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-46.
11. el-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001; 5: 87-107, vi.
12. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000; 132: 296-305.
13. Silveira TR, Da Fonseca JC, Rivera L, Fay OH, Tapia R, Santos JI, Urdeneta E, Clemens SA. Hepatitis B seroprevalence in Latin America. Rev Panam Salud Publica 1999; 6: 378-83.
14. Tran TT, Martin P. Hepatitis B: epidemiology and natural history. Clin Liver Dis 2004; 8: 255-66.
15. Ocama P, Opio CK, Lee WM. Hepatitis B virus infection: current status. Am J Med 2005; 118: 1413.
16. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142-61.
17. Chiquete E, Sanchez LV, Becerra G, Quintero A, Maldonado M, Panduro A. Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center. Ann Hepatol 2005; 4: 275-8.
18. Shrestha SK, Bhattarai MD. Study of hepatitis B among different categories of health care workers. J Coll Physicians Surg Pak 2006; 16: 108-11.
19. Wong T, Lee SS. Hepatitis C: a review for primary care physicians. CMAJ 2006; 174: 649-659.
20. Berry AJ. Needle stick and other safety issues. Anesthesiol Clin North America 2004; 22: 493-508, vii.
21. Rischitelli G, Lasarev M, McCauley L. Career risk of hepatitis C virus infection among U.S. emergency medical and public safety workers. J Occup Environ Med 2005; 47: 1174-81.
22. Sulkowski MS, Ray SC, Thomas DL. Needlestick transmission of hepatitis C. JAMA 2002; 287: 2406-13.
23. Suzuki T, Omata K, Satoh, Miyasaka T, Arai C, Maeda M, Matsuno T, Miyamura T. Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients. J Clin Microbiol 2005; 43: 4413-7.
24. Dusheiko GM, Smith M, Scheuer PJ. Hepatitis C virus transmitted by human bite. Lancet 1990; 336: 503-4.
25. Mattner F, Tillmann HL. Proof of alleged transmission of hepatitis C virus by a conjunctival blood splash. Am J Infect Control 2004; 32: 375-6.
26. Mendez-Sanchez N, Ponciano-Radriguez G, Chavez-Tapia NC, Motola-Kuba D, Almeda-Valdes P, Sanchez-Lara K, Ramos MH, Uribe M. Prevalence of Hepatitis C Infection in a Population of Asymptomatic People in a Checkup Unit in Mexico City. Dig Dis Sci 2005; 50: 733-737.